TCL Archive In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7% January 28, 1977
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012